Novartis | NVS - Equity Capital And Reserves

Novartis reported $59.34B in Equity Capital and Reserves for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Equity Capital And Reserves Change
Amgen AMGN:US USD 3.66B 8M
AstraZeneca AZN:LN USD 37.04B 1.9B
Astrazeneca AZN:US USD 37.04B 1.9B
Biogen BIIB:US USD 13.4B 622.4M
Canopy Growth Corp WEED:CN CAD 1.49B 191.63M
Catalent CTLT:US USD 4.91B 212M
Corcept Therapeutics CORT:US USD 501.84M 28.48M
Drreddys Laboratories RDY:US INR 220.27B 14.05B
Endo International Ordinary Shares ENDP:US USD -3925041000 726.97M
Gilead Sciences GILD:US USD 21.21B 128M
GlaxoSmithKline GSK:LN GBP 10.6B 1.45B
Glaxosmithkline GSK:US GBP 10.6B 1.45B
Horizon Pharma HZNP:US USD 5.07B 38.49M
JAZZ PHA JAZZ:US USD 3.09B 340.54M
Lannett LCI:US USD -312274000 34.71M
Novartis NOVN:VX USD 59.34B 1.48B
Pacira Pharmaceuticals PCRX:US USD 775.01M 4.89M
Perrigo Ordinary Shares PRGO:US USD 4.84B 239.4M
Phibro Animal Health PAHC:US USD 268.37M 5.61M
Prestige Brands PBH:US USD 1.69B 67.02M
Roche Holding ROG:VX 27.99B 2.8B
Supernus Pharmaceuticals SUPN:US USD 886.2M 33.41M
Teva Pharmaceutical Industries TEVA:US USD 7.9B 871M
Valeant Pharmaceuticals VRX:CN USD -692000000 167M
Zoetis ZTS:US USD 4.4B 258M